00:00
00:00
00:00
ValiRx Plc - ValiSeek Clinical Development Update

Further to their announcement on 3 November 2016 regarding the successful dosing of the first patient with VAL401, ValiSeek has confirmed the initiation of the process to commission a second clinical testing site. Dr Suzy Dilly provides an update on this clinical development

Suzanne Dilly
CEO, ValiSeek Limited

Company Events - VALIRX PLC